[1] Al-Azemi M, Kyrou D, Kolibianakis E M, et al. Elevated progesterone during ovarian stimulation for IVF[J]. Reprod Biomed Online, 2012, 24(4): 381
[2] Smitz J, Ron-El R, Tarlatzis B C. The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: Experience from three centres[J]. Hum Reproduction, 1992, 7:49
[3] Bosch E, Valenica I, Escudero E, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome[J]. Fertility Sterility, 2003, 80(6): 1444
[4] Ubaldi F, Albano C, Peukert M, et al. Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles[J]. Hum Reproduction, 1996, 11(7): 1405
[5] Hill M J, Royster G D, Healy M W, et al. Are good patient and embryo characteristics protective against the negative effect of elevated progesterone level on the day of oocyte maturation[J]. Fertility Sterility, 2015, 103(6): 1477
[6] Venetis C A, Kolibianakis E M, Papanikolaou E, et al. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis[J]. Hum Reproduction Update, 2007, 13(4): 343
[7] Venetis C A, Kolibianakis E M, Bosdou J K, et al. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles[J]. Hum Reproduction Update, 2013, 19(5): 433
[8] Simón C, Martín J C, Pellicer A. Paracrine regulators of implantation [J]. Best Pract Res Clin Obstetrics Gynaecol, 2000, 14(5): 815
[9] Kolibianakis E M, Venetis C A, Bontis J, et al. Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: A systematic review and Meta-analysis[J]. Curr Pharmaceut Biotechnol, 2012, 13(3): 464
[10] Lawrenz B, Labarta E, Fatemi H, et al. Premature progesterone elevation: targets and rescue strategies[J]. Fertil Steril, 2018, 109(4): 577
[11] Van Vaerenbergh I, Fatemi H M, Blockeel C, et al. Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression[J]. Reprod Biom Online, 2011, 22(3): 263
[12] Labarta E, Martínez-Conejero J A, Alamá P, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis [J]. Hum Reproduction, 2011, 26(7): 1813
[13] Li R, Qiao J, Wang L, et al. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration[J]. Reprod Biol Endocrinol RB&E, 2011, 9:29
[14] Haouzi D, Bissonnette L, Gala A, et al. Endometrial receptivity profile in patients with premature progesterone elevation on the day of HCG administration[J]. Biomed Res Int, 2014, 2014:951937
[15] Papanikolaou E G, Kolibianakis E M, Pozzobon C, et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer[J]. Fertil Steril, 2009, 91(3): 949
[16] Corti L, Papaleo E, Pagliardini L, et al. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law [J]. Eur J Obstetrics Gynecol Reproduct Biol, 2013, 171(1): 73
[17] Ferraretti A P, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: Is there a need for revision[J]. Hum Reproduction, 2014, 29(9): 1842
[18] Cooper T G, Noonan E, Von Eckardstein S, et al. World Health Organization reference values for human semen characteristics[J]. Hum Reprod Update, 2010, 16(3): 231
[19] Desai N N, Goldstein J, Rowland D Y, et al. Morphological evaluation of human embryos and derivation of an embryo quality scoring system specific for day 3 embryos: a preliminary study[J]. Hum Reproduction, 2000, 15(10): 2190
[20] Pelinck M J, De Vos M, Dekens M, et al. Embryos cultured in vitro with multinucleated blastomeres have poor implantation potential in human in-vitro fertilization and intracytoplasmic sperm injection[J]. Hum Reprod, 1998, 13(4): 960
[21] O’shea L C, Mehta J, Lonergan P, et al. Developmental competence in oocytes and cumulus cells: candidate genes and networks[J]. Systems Biol Reprod Med, 2012, 58(2): 88
[22] Fair T, Lonergan P. The Role of Progesterone in Oocyte Acquisition of Developmental Competence [J]. Reprod Domestic Animals, 2012, 47(s4): 142
[23] Lahoud R, Kwik M, Ryan J, et al. Elevated progesterone in GnRH agonist down regulated in vitro fertilisation(IVFICSI) cycles reduces live birth rates but not embryo quality[J]. Arch Gynecol Obstetrics, 2012, 285(2): 535
[24] Huang B, Ren X, Wu L, et al. Elevated progesterone levels on the day of oocyte maturation May affect top quality embryo IVF cycles[J]. PLoS One, 2016, 11(1): e0145895
[25] Vannis V S, Somiglian E, Reschini M, et al. Top quality blastocyst formation rates in relation to progesterone levels on the day of oocyte maturation in GnRH antagonist IVF/ICSI cycles[J]. PLoS One, 2017, 12(5): e0176482
[26] Liu L, Zhou F, Lin X, et al. Recurrent IVF failure is associated with elevated progesterone on the day of hCG administration[J]. Europ J Obst Gynecol Reproduct Biol, 2013, 171(1): 78
[27] Racca A, Santos-Ribeiro S, De Munck N, et al. Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality[J]. Hum Reprod, 2018, 33(5): 860
[28] Bu Z, Zhao F, Wang K, et al. Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study [J]. PLoS ONE, 2014, 9(6): e100011
[29] Lawrenz B, Fatemi H M. Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity[J]. Reprod Biom Online, 2017, 34(4): 422
[30] Xu B, Li Z, Zhang H, et al. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles[J]. Fertil Steril, 2012, 97(6): 1321
[31] Requena A, Cruz M, Bosch E, et al. High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study[J]. Reproduct Biol Endocrinol, 2014, 12(1): 69